Literature DB >> 7228989

Lithium induces abnormal calcium-regulated PTH release in dispersed bovine parathyroid cells.

E M Brown.   

Abstract

The effects of lithium on calcium-regulated parathyroid hormone (PTH) release were assessed in collagenase-dispersed bovine parathyroid cells. Preincubation for 4 hours with LiCl caused a dose-dependent increase in the concentration of calcium required for half-maximal inhibition of immunoreactive PTH release (the "set-point" for calcium). A significant increase in "set-point" was observed following exposure to 1.25 mM lithium, a concentration within the therapeutic range for man. This effect required preincubation with LiCl, was not seen with NaCl or KCl, and persisted despite removal of extracellular lithium. This lithium-induced abnormality in calcium-regulated PTH secretion may be a useful model system for analyzing the analogous defect in secretory control in primary hyperparathyroidism.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7228989     DOI: 10.1210/jcem-52-5-1046

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

1.  Identification of Acer2 as a First Susceptibility Gene for Lithium-Induced Nephrogenic Diabetes Insipidus in Mice.

Authors:  Theun de Groot; Lena K Ebert; Birgitte Mønster Christensen; Karolina Andralojc; Lydie Cheval; Alain Doucet; Cungui Mao; Ruben Baumgarten; Benjamin E Low; Roger Sandhoff; Michael V Wiles; Peter M T Deen; Ron Korstanje
Journal:  J Am Soc Nephrol       Date:  2019-09-26       Impact factor: 10.121

2.  Chronic lithium intake and hyperparathyroidism.

Authors:  A Prasad
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

3.  Relation of hyperparathyroidism and hypercalcemia to bipolar and psychotic disorders.

Authors:  Chioma O Enyi; Brendan D'Souza; Linda Barloon; Onyedika J Ilonze; Ranjit Chacko
Journal:  Proc (Bayl Univ Med Cent)       Date:  2022-04-08

4.  Lithium and symptomatic hyperparathyroidism.

Authors:  J Ananth; S E Dubin
Journal:  J R Soc Med       Date:  1983-12       Impact factor: 5.344

5.  Acetazolamide Attenuates Lithium-Induced Nephrogenic Diabetes Insipidus.

Authors:  Theun de Groot; Anne P Sinke; Marleen L A Kortenoeven; Mohammad Alsady; Ruben Baumgarten; Olivier Devuyst; Johannes Loffing; Jack F Wetzels; Peter M T Deen
Journal:  J Am Soc Nephrol       Date:  2015-11-16       Impact factor: 10.121

6.  Effects of lithium on synaptosomal Ca2+ fluxes.

Authors:  M L Koenig; R S Jope
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

7.  Appropriate surgical treatment of lithium-associated hyperparathyroidism.

Authors:  Evie Carchman; Jennifer Ogilvie; Jennifer Holst; John Yim; Sally Carty
Journal:  World J Surg       Date:  2008-10       Impact factor: 3.352

Review 8.  Lithium therapy and hyperparathyroidism: an evidence-based assessment.

Authors:  Brian D Saunders; Erika F H Saunders; Paul G Gauger
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.